263 related articles for article (PubMed ID: 15922251)
1. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy.
Nzila A; Ward SA; Marsh K; Sims PF; Hyde JE
Trends Parasitol; 2005 Jun; 21(6):292-8. PubMed ID: 15922251
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance of malaria parasites to antifolates.
Gregson A; Plowe CV
Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of folate uptake inhibition in Plasmodium falciparum.
Nzila AM; Kokwaro G; Winstanley PA; Marsh K; Ward SA
Trends Parasitol; 2004 Mar; 20(3):109-12. PubMed ID: 16676416
[TBL] [Abstract][Full Text] [Related]
4. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
[TBL] [Abstract][Full Text] [Related]
5. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
Nzila A
J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial drug development and new targets.
Macreadie I; Ginsburg H; Sirawaraporn W; Tilley L
Parasitol Today; 2000 Oct; 16(10):438-44. PubMed ID: 11006476
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.
Heinberg A; Kirkman L
Ann N Y Acad Sci; 2015 Apr; 1342(1):10-8. PubMed ID: 25694157
[TBL] [Abstract][Full Text] [Related]
9. The folate metabolic network of Falciparum malaria.
Salcedo-Sora JE; Ward SA
Mol Biochem Parasitol; 2013 Mar; 188(1):51-62. PubMed ID: 23454873
[TBL] [Abstract][Full Text] [Related]
10. Chemoresistance in falciparum malaria.
May J; Meyer CG
Trends Parasitol; 2003 Oct; 19(10):432-5; discussion 435-6. PubMed ID: 14519577
[No Abstract] [Full Text] [Related]
11. The mode of action and the mechanism of resistance to antimalarial drugs.
Foote SJ; Cowman AF
Acta Trop; 1994 Mar; 56(2-3):157-71. PubMed ID: 8203302
[TBL] [Abstract][Full Text] [Related]
12. Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum.
Wang P; Nirmalan N; Wang Q; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 May; 135(1):77-87. PubMed ID: 15287589
[TBL] [Abstract][Full Text] [Related]
13. Molecular approaches to the spreading problem of drug resistant malaria.
Plowe CV; Wellems TE
Adv Exp Med Biol; 1995; 390():197-209. PubMed ID: 8718614
[No Abstract] [Full Text] [Related]
14. Exploring the folate pathway in Plasmodium falciparum.
Hyde JE
Acta Trop; 2005 Jun; 94(3):191-206. PubMed ID: 15845349
[TBL] [Abstract][Full Text] [Related]
15. Comparative folate metabolism in humans and malaria parasites (part II): activities as yet untargeted or specific to Plasmodium.
Nzila A; Ward SA; Marsh K; Sims PF; Hyde JE
Trends Parasitol; 2005 Jul; 21(7):334-9. PubMed ID: 15936248
[TBL] [Abstract][Full Text] [Related]
16. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
Kinyanjui SM; Mberu EK; Winstanley PA; Jacobus DP; Watkins WM
Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
[TBL] [Abstract][Full Text] [Related]
17. Resistance to antifolates in Plasmodium falciparum, the causative agent of tropical malaria.
Warhurst DC
Sci Prog; 2002; 85(Pt 1):89-111. PubMed ID: 11969121
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
19. A genetically hard-wired metabolic transcriptome in Plasmodium falciparum fails to mount protective responses to lethal antifolates.
Ganesan K; Ponmee N; Jiang L; Fowble JW; White J; Kamchonwongpaisan S; Yuthavong Y; Wilairat P; Rathod PK
PLoS Pathog; 2008 Nov; 4(11):e1000214. PubMed ID: 19023412
[TBL] [Abstract][Full Text] [Related]
20. MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparum.
Rijpma SR; van der Velden M; Bilos A; Jansen RS; Mahakena S; Russel FG; Sauerwein RW; van de Wetering K; Koenderink JB
FEBS Lett; 2016 Feb; 590(4):482-92. PubMed ID: 26900081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
